Eleanor and Lou Gehrig MDA/ALS Research Center, Columbia University
Projects Funded by MDA's Wings Over Wall Street 2002: Research Accomplishment
|
| Investigators | Project | Major Accomplishment | Total Funding |
| Paul Gordon, M.D. | Clinical trial of Glatiramer (Copaxone) in ALS |
*Translation from animal study to human project
* All planning completed with grant submitted to MDA
* Institutional approval and drug preparation
* The cost of drugs carried over to this year | $167,199 |
| Hiroshi Mitsumoto, M.D. | ALS Marker Study |
* Novel technology, MR spectroscopy, and transcranial magnetic stimulation can distinguish ALS from other motor neuron diseases
* Absolute quantification of NAA has been developed
* Several presentations have been made at national and international meetings | $92,199 |
| Hiroshi Mitsumoto, M.D. | Lou Gehrig Centennial Conference on ALS |
* A successful international meeting that focused on clinical trials in ALS
* Edited 30 manuscripts and prepared for publication (June 2004) | $25,000 |
| Hiroshi Mitsumoto, M.D. and Ruth Ottman, Ph.D. | Genetic-Environmental
Epidemiology | * Detailed planning, project development, and grant submission to MDA
* A consensus conference on this topic was held in March with 11 national and international collaborators and 10 members of the Columbia faculty.
* Study Questionnaire developed. | $50,000 |
| Thomas Jessell, Ph.D. | Characterization of Motor Neuron Progenitor Cells |
* Demonstration that retinoids function in an essential manner to promote motor neuron progenitor identity (Novitch et al. Neuron 2003)
* Demonstration that FACS sorted motor neuron progenitors can differentiate into motor neurons in vitro (Agalliu et al. In preparation) | $125,000 |
| Thomas Jessell, Ph.D. | Directed Differentiation of Embryonic Stem Cells into Motor Neurons |
* Demonstration that ES cells can differentiate into motor neurons (Wichterle et al. Cell, 2002)
* Demonstration that ES cell derived motor neurons have appropriate biophysical properties (Miles et al, J. Neuroscience)
* Demonstration that ES cell derived motor neurons acquire columnar and pool identities (Wichterle et al. In Preparation)
* Demonstration that human ES cells can give rise to motor neurons (Wichterle, Rajagopal, Jessell, Melton; In Preparation) | $200,000 |
| Serge Przedborski, M.D., Ph.D. | Role of Endoplasmic Reticulum Stress in ALS Neurodegeneration |
* Most of the key pathways of the ER stressed have been mapped in both ALS rats and post-mortem tissue.
* Mutant animals with ALS mutations but lacking key factors of the ER stress are currently evaluated | $150,000 |
| Serge Przedborski, M.D., Ph.D. | Behavior of Motor neurons Derived From Embryonic Stem Cells in Animal Models of ALS |
* All of the technical aspects related to the protocol of stem cells preparation and grafting technical have been completed.
* Young and old ALS rats are currently evaluated after implantation of stem cells | Included in the above budget |
| William Dauer, M.D. | Generating and Characterizing an Inducible Model of ALS |
* Generating a tetracycline inducible line of SOD G93A mice
* Performing behavioral and pathologic studies of these mice to determine whether SOD-related neurodegeneration is reversible. |
$180,000 |
| TOTAL | | | $989,398 |